Protocol · Oncology Support
Thyroid Cancer Supportive Care Protocol
Selenium and Vitamin D are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Thyroid Cancer Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Selenium | Amount listed: 100–200 mcg daily (avoid excess; upper limit 400 mcg) | Essential for thyroid function; may support thyroid health; some studies suggest protective effects | Not graded yet | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily (maintain adequate levels) | Deficiency associated with worse thyroid cancer outcomes; supports immune function; may have anti-cancer properties
| Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory; may support overall health during cancer treatment | Not graded yet | |
| Curcumin | Amount listed: 500–1,500 mg daily with enhanced absorption | Anti-inflammatory; laboratory studies show anti-thyroid cancer effects; human clinical data limited | Not graded yet | |
| Green Tea Extract (EGCG) | Amount listed: 250–500 mg EGCG daily | Antioxidant; some laboratory studies suggest effects on thyroid cancer cells | Not graded yet | |
| Vitamin E | Amount listed: 400 IU daily (mixed tocopherols) | Antioxidant; general cancer supportive care | Not graded yet | |
| B-Complex Vitamins | Amount listed: B-complex daily | Supports energy and metabolism; important during cancer treatment | Not graded yet | |
| Magnesium | Amount listed: 300–400 mg daily | Supports muscle function and energy; often depleted during cancer treatment | Not graded yet | |
How this protocol works
In plain language
Thyroid cancer is cancer that develops in the thyroid gland, a butterfly-shaped gland in the neck that produces hormones regulating metabolism. Thyroid cancer is one of the most treatable cancers, with excellent survival rates, especially for differentiated types (papillary and follicular).
TYPES OF THYROID CANCER:
- Papillary (80-85%): Most common; excellent prognosis
- Follicular (10-15%): Good prognosis
- Medullary (3-5%): Arises from C cells; may be hereditary (MEN2)
- Anaplastic (<2%): Aggressive; older patients
CRITICAL: Thyroid cancer treatment requires specialized medical care. This protocol is SUPPORTIVE ONLY and does not replace standard treatment.
STANDARD TREATMENT:
- Surgery: Thyroidectomy (total or partial)
- Radioactive iodine (RAI): For differentiated cancers after surgery
- Thyroid hormone replacement: Levothyroxine for life; often suppressive dose
- External radiation: For certain cases
- Targeted therapies: For advanced or resistant disease
- Surveillance: Regular imaging and thyroglobulin monitoring
IMPORTANT NOTES:
- Iodine: Avoid excess before RAI treatment; low-iodine diet required
- Soy: May interfere with levothyroxine absorption
- Calcium: May be needed if parathyroids affected by surgery
Selenium* supports thyroid function and may have protective effects.
Vitamin D* deficiency is associated with worse thyroid cancer outcomes.
Omega-3s and Curcumin* provide anti-inflammatory support.
Expected timeline: Thyroid cancer treatment is ongoing. Supplements support overall health. Always discuss supplements with oncology team.